AI BIO Snapshot Meeting

Time: 11:00 AM EST, Oct 4, 2025

Location: Online

Registration Fee: Free

Scan to Register Closes at 9:00 PM EST on 10/3/2025 A Zoom link will be sent around 8:00 PM EST on 10/2

Scan to Submit Closes at 11:59 PM EST on 10/1/2025 Please kindly provide only generic information Avoid including any proprietary details

Meeting Schedule

This session covers AI research across 6 distinct fields: genomics, transcriptomics, protein engineering, small-molecule drug design, materials science and drug delivery systems, and foundation models.

11:00 - 11:20

NSF & Getting Started

NSF New England I-Corps Hub Perspective

This session for students and post-docs introduces the new NSF New England I-Corp Hub and NSF programs and funding pathways to advance your research and ideas towards commercialization, entrepreneurship, and broader impact.

11:25 - 11:40

Dr. Vijay Pande

Co-Founder of VZVC, Founder and former Managing Partner of the a16z Bio + Health Fund, Adjunct Professor at Stanford University, Co-founded Globavir Biosciences, On the boards of more than 14 companies including Slingshot AI, Apeel Sciences, Bayesian Health, Devoted Health, Nautilus Biotechnology and Scribe Therapeutics.

AI Meets Biomedicine: Innovation and Investment

11:45 - 12:00 Keynote

Prof. David Baker

Director of the Institute for Protein Design at University of Washington, Co-founder of a number of companies including Xaira Therapeutics, Prospect Genomics, Icosavax, PvP Biologics, Pregenen and Neoleukin Therapeutics.

Nobel Prize in Chemistry 2024

Computational protein design

12:05 - 12:25

Dr. Žiga Avsec

Senior Staff Research Scientist at Google DeepMind

AlphaGenome (bioRxiv)

12:30 - 12:50

Dr. Yusuf Roohani

Machine Learning Group Lead at Arc Institute, Visiting Scholar at Stanford

Virtual Cell Challenge (Cell), In silico prediction of gene expression using STATE model (bioRxiv)

12:55 - 1:15

Prof. Manolis Kellis

Head of Computational Biology Group at MIT

Beyond chatbots: unleashing human creativity through visual AI, multimodal deep representation learning, and agentic workflows in chemistry, biological structures, and functions

1:20 - 1:40

Dr. Kevin Yang

Principal Researcher at Microsoft, Trainee of Dr. Frances Arnold

AI-aided Protein Engineering. Nature Methods Papers 1 and 2

1:45 - 2:05

Dr. Jacob Witten

Postdoc Fellow with Dr. Robert Langer and Dr. Daniel Anderson at MIT, Received Assistant Professor Offers

Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy. Nature Biotechnology

2:10 - 2:30

Dr. Pat Walters

Chief Scientist at OpenADMET, with prior leadership roles at Relay Therapeutics (NASDAQ: RLAY) and Vertex Pharmaceuticals (NASDAQ: VRTX)

How AI is impacting drug discovery and current challenges in the field

AI BIO Startup Connect

This session connects startups with talent. Open to everyone. Free.

2:35 - 2:37

Lub Dub Lab

A startup from MIT Sloan is seeking technical experts and talent.

AI BIO Startup Spotlight & Pitch Session

All startups are in early stages (pre-B), with some still in stealth mode. To protect their information, this session is open only to invited investors. Free.

2:50 - 3:00